Glucagon-Like Peptide-1 (GLP-1): The Hormone Biology

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Welcome to the PlexusDx Education Hub, where we translate GLP-1 science, weight-management options, and the genetic signals underneath them into plain language. Browse the full Peptides & GLP-1 library.

Before it was a blockbuster drug class, GLP-1 was — and still is — a hormone your own body makes. This article deliberately starts with the biology of glucagon-like peptide-1 itself: where it comes from, what it does minute to minute, why it disappears so fast, and only then how medicine borrowed the design. Understanding the hormone is the cleanest way to understand everything built on top of it.

The hormone your gut makes

Glucagon-like peptide-1 is an incretin hormone secreted by the L-cells of the small intestine in response to food intake. It is a compact peptide, roughly 30 to 31 amino acids long, and it is released as part of the body's natural post-meal signaling. In other words, GLP-1 is not something invented in a lab — it is a normal messenger your digestive system produces every time you eat.

What GLP-1 does after a meal

Once released, the hormone gets to work on several fronts at once. It stimulates glucose-dependent insulin secretion from pancreatic beta cells, suppresses glucagon release, slows the rate at which the stomach empties, and engages satiety circuits in the hypothalamus. Together these actions coordinate the body's response to incoming food — managing blood sugar while signaling fullness to the brain.

Why the natural hormone fades so quickly

For all that activity, native GLP-1 has an extremely short life in the bloodstream — about two minutes — because the enzyme dipeptidyl peptidase-4, or DPP-4, degrades it almost immediately. That built-in brevity is central to how the hormone works physiologically, and it is exactly the feature that made turning GLP-1 into a lasting medication so difficult.

How medicine reproduced the signal

GLP-1 receptor agonist drugs are engineered to resist DPP-4, stretching their half-life from the hormone's two minutes to days or even weeks. They bind the same receptor as the native hormone and reproduce the same downstream effects on insulin, glucagon, gastric emptying, and satiety. Tirzepatide-based compounds go further, also activating the related GIP receptor — a key molecular distinction in the class as of April 2026. Approved agents include exenatide (Byetta in 2005), liraglutide (Victoza in 2010, Saxenda in 2014), dulaglutide (Trulicity in 2014), semaglutide (Ozempic in 2017, Rybelsus in 2019, Wegovy in 2021), and tirzepatide (Mounjaro in 2022, Zepbound in 2023). Orforglipron remain investigational.

Genetic variation in GLP-1 biology

The hormone's pathway carries natural genetic variation from person to person. GLP1R encodes the receptor and influences its density and signaling; FTO shapes appetite and fat-mass set-point; MC4R governs hypothalamic satiety; and TCF7L2 affects insulin secretion and incretin response. The PlexusDx Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights across these traits — educational trait mapping, never a pharmacogenomic prediction of how a drug will perform. Explored with the Weight Management Protocols, it grounds any decision in your own biology.

More on PlexusDx: GLP-1 Receptor Agonist and GLP-1 Drugs.

Why starting with the hormone helps

Leading with the biology rather than the brand names pays a quiet dividend: almost everything about the medications makes more sense once the hormone is clear. The reason the drugs need engineering is the hormone's two-minute half-life. The reason they produce the effects they do is that they copy the hormone's own actions on insulin, glucagon, gastric emptying, and satiety. Even the newest dual-receptor agents are best understood as extensions of a natural signaling system rather than inventions from scratch.

That grounding also frames the genetic layer honestly. Your own GLP-1 biology is shaped by inherited variation long before any medication enters the picture, so understanding the hormone first makes the role of genes feel less like a marketing hook and more like what it is — the baseline terrain every downstream decision is built on.

Frequently Asked Questions

What does glucagon-like peptide-1 do naturally?

As an incretin hormone released after meals, GLP-1 stimulates glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and signals satiety to the brain. These coordinated actions help the body manage blood sugar and appetite in response to food, all before any medication enters the picture.

Why does the body break GLP-1 down so fast?

Native GLP-1 has a circulating half-life of only about two minutes because the enzyme DPP-4 degrades it almost immediately after release. This rapid clearance is a normal feature of the hormone's short-acting, meal-linked role, and it is the specific obstacle that drug developers had to engineer around.

How is the hormone different from the medication?

The medication is a receptor agonist engineered to resist DPP-4, so it lasts days to weeks instead of minutes while binding the same receptor and producing the same effects. Some drugs, like tirzepatide, add GIP receptor activity that the natural hormone does not have, extending beyond pure GLP-1 signaling.

Do my genes change how my own GLP-1 works?

Genetic variants in FTO and MC4R, and TCF7L2 shape baseline appetite, incretin signaling, and energy balance, describing the terrain your GLP-1 biology operates on. The Precision Peptide Genetic Test maps these variants for education — it does not predict response to any medication or serve as a pharmacogenomic result.

Keep exploring inside the PlexusDx Education Hub. Return to all Peptides & GLP-1 education.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.